|
Patient no.
|
Age
|
Sex
|
Primary site
|
Histopathology
|
Accumulated dose of prior RT (Gy)
|
Recurrent stage
|
Tumor diameter (cm)
|
|---|
|
1
|
68
|
M
|
Hypopharynx
|
SCC
|
136.4 in 2 courses
|
T1N2a
|
4
|
|
2
|
67
|
M
|
Tongue
|
SCC
|
66
|
T2N2a
|
9.5
|
|
3
|
49
|
F
|
Nasal cavity
|
Sinonasal carcinoma
|
120 in 2 courses
|
T4N0
|
5
|
|
4
|
71
|
M
|
Gingiva
|
SCC
|
66
|
T4N0
|
7.5
|
|
5
|
46
|
M
|
Nasopharynx
|
Undifferentiated ca
|
136 in 2 courses
|
T4N0
|
3.9
|
|
6
|
58
|
F
|
Nasopharynx
|
Non-keratinizing ca
|
122 in 2 courses
|
T3N0
|
2.5
|
|
7
|
57
|
M
|
Tongue
|
SCC
|
70
|
T3N0
|
4.5
|
|
8
|
52
|
M
|
Tongue
|
SCC
|
70
|
T4aN0
|
5.3
|
|
9
|
54
|
M
|
Maxillary sinus
|
SCC
|
70
|
T3N0
|
8.9
|
|
10
|
54
|
M
|
Tongue
|
SCC
|
63
|
T0N2b
|
6.0
|
|
11
|
48
|
M
|
Tongue
|
Spindle cell sarcoma
|
107 in 2 courses
|
T4bN0
|
6.0
|
|
12
|
74
|
M
|
Maxillary sinus
|
SCC
|
105 in 2 courses
|
T2N0
|
3.5
|
|
13
|
51
|
M
|
Parotid gland
|
Adenocarcinoma
|
136 in 2 courses
|
T4N0
|
5.8
|
|
14
|
56
|
M
|
Buccal mucosa
|
SCC
|
125.9 in 2 courses
|
T1N0
|
0.9
|
|
15
|
40
|
M
|
Hypopharynx
|
SCC
|
95 in 2 courses
|
T3N0
|
4.7
|
|
16
|
59
|
M
|
Nasopharynx
|
Non-keratinizing ca
|
136 in 2 courses
|
T3N0
|
3.9
|
|
17
|
62
|
M
|
Buccal mucosa
|
SCC
|
64
|
T4aN0
|
6.4
|
- BNCT boron neutron capture therapy, SCC squamous cell carcinoma
